Head and Neck Cancers Coverage from Every Angle
Advertisement
Advertisement

Nadeem Riaz, MD, on Immunotherapy Biomarkers in Head and Neck Cancer: Guiding Treatment Decisions

Posted: Tuesday, March 24, 2020

Nadeem Riaz, MD, of Memorial Sloan Kettering Cancer Center, discusses the distinction between biomarkers that may be used to select and guide therapy vs those that may be prognostic, as well as the details of testing—timing, access, and cost.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.